Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area Sort ascending
Country
Application Due Date
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Oncology Japan
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Title
Grant Type
Focus Area Sort ascending
Country
Application Due Date
Educational Activities to Improve Vaccination Rate beyond Clinical Departments
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Burden of Community Acquired Pneumonia
Release Date:
Review Process: Pfizer Internal
Research Vaccines USA
COVID-19 Vaccine Patient Education: Addressing Vaccine Hesitancy
Release Date:
Review Process: Pfizer Internal
Education Vaccines All
Assessment of on-time immunization coverage in children under 2 years of age in Canada
Release Date:
Review Process: Pfizer Internal
Research Vaccines Canada
Knowledge Gaps in Updated Pneumococcal Immunization Recommendations
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Vaccine Preventable Diseases – COVID-19 (closed early)
Release Date:
Review Process: Pfizer Internal
Research Vaccines All
Serotyping of Streptococcus pneumoniae
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Implementing Updated Pneumococcal Immunization Recommendations in Adults
Release Date:
Review Process: Pfizer Internal
Quality Improvement Vaccines USA
Vaccines for All: Longevity Unleashed for Everyone (VALUE)
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Japan
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Spain
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain